Filing Details

Accession Number:
0001209191-21-030320
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-05 13:00:00
Reporting Period:
2021-05-03
Accepted Time:
2021-05-05 16:19:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1651944 Dermtech Inc. DMTK Services-Medical Laboratories (8071) 842870849
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1787176 John Dobak C/O Dermtech, Inc.
11099 N. Torrey Pines Road, Suite 100
La Jolla CA 92037
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-05-03 16,021 $40.51 499,095 No 4 S Direct
Common Stock Disposition 2021-05-03 6,808 $41.53 492,287 No 4 S Direct
Common Stock Disposition 2021-05-03 2,171 $42.45 490,116 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2021.
  2. This transaction was executed in multiple trades at prices ranging from $40.00 to $40.93, inclusive. The reported price reflects the weighted-average sale price.
  3. This transaction was executed in multiple trades at prices ranging from $41.00 to $41.91, inclusive. The reported price reflects the weighted-average sale price.
  4. This transaction was executed in multiple trades at prices ranging from $42.02 to $42.87, inclusive. The reported price reflects the weighted-average sale price.
  5. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) of this Form 4.